DNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers.

MLA

Gull, Nicole, et al. “DNA Methylation and Transcriptomic Features Are Preserved throughout Disease Recurrence and Chemoresistance in High Grade Serous Ovarian Cancers.” Journal of Experimental & Clinical Cancer Research : CR, vol. 41, no. 1, July 2022, p. 232. EBSCOhost, https://doi.org/10.1186/s13046-022-02440-z.

APA

Gull, N., Jones, M. R., Peng, P.-C., Coetzee, S. G., Silva, T. C., Plummer, J. T., Reyes, A. L. P., Davis, B. D., Chen, S. S., Lawrenson, K., Lester, J., Walsh, C., Rimel, B. J., Li, A. J., Cass, I., Berg, Y., Govindavari, J.-P. B., Rutgers, J. K. L., Berman, B. P., … Gayther, S. A. (2022). DNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers. Journal of Experimental & Clinical Cancer Research : CR, 41(1), 232. https://doi.org/10.1186/s13046-022-02440-z

Chicago

Gull, Nicole, Michelle R Jones, Pei-Chen Peng, Simon G Coetzee, Tiago C Silva, Jasmine T Plummer, Alberto Luiz P Reyes, et al. 2022. “DNA Methylation and Transcriptomic Features Are Preserved throughout Disease Recurrence and Chemoresistance in High Grade Serous Ovarian Cancers.” Journal of Experimental & Clinical Cancer Research : CR 41 (1): 232. doi:10.1186/s13046-022-02440-z.